Plasma-based longitudinal mutation monitoring as a potential predictor of disease progression in subjects with adenocarcinoma in advanced non-small cell lung cancer | BMC Cancer User montaukwhaler, in the non small cell lung cancer subreddit, 18 Sep 2020